Table 2.
Compound | Conc. (g/mL) | Pathogens | ||||
---|---|---|---|---|---|---|
Aa | B | C | D | E | ||
Tobramycin | 0.010 | 16b | 14 | 24 | - | 16 |
0.005 | 10 | 12 | 16 | - | 10 | |
2a | 0.010 | 10 | 13 | 14 | - | 9 |
0.005 | 8 | 10 | 8 | - | - | |
2b | 0.010 | 13 | 14 | 15 | - | 8 |
0.005 | 9 | 10 | 9 | - | - | |
2c | 0.010 | - | 9 | 13 | - | 9 |
0.005 | - | - | 9 | - | - | |
2d | 0.010 | 8 | 9 | 9 | - | 9 |
0.005 | - | - | - | - | - | |
3a | 0.010 | 8 | 13 | 14 | 9 | 15 |
0.005 | - | 10 | 8 | - | 11 | |
3b | 0.010 | 10 | 11 | 12 | - | 16 |
0.005 | - | 10 | 9 | - | 11 | |
3c | 0.010 | 8 | 8 | 11 | 8 | 15 |
0.005 | - | - | 10 | - | 11 | |
3d | 0.010 | 8 | - | 9 | - | 9 |
0.005 | - | - | - | - | - | |
3e | 0.010 | 15 | 14 | 21 | 13 | 18 |
0.005 | 14 | 10 | 15 | 10 | 11 |
a A: Staphylococcus aureus; B: Escherichia coli; C: Candida albicans; D: local resistant Pseudomonas aeruginosa; E: reference Pseudomonas aeruginosa ATCC 27853.
b Inhibition zone diameter measured in mm.